We are true advisory partners, working with our clients to fully understand their long term plans so we can structure the deal to contribute to this goal.
Negotiating deals extends beyond discussing deal terms. There are a myriad of details that need to be anticipated and managed, so it requires an in-depth understanding of drug development, commercialization, risk management, contract structuring, alliance management, finance, and negotiation strategy. This is why clients choose DNA Ink over firms who leverage investors or bankers to negotiate deals. DNA Ink provides an experienced, well known and respected, executive-level, cross-functional team that mirrors big phama’s team to manage the entire deal process. Our clients understand that the devil is in the detail and they want experience on their side of the negotiation table
Because we fully commit ourselves to each deal, we are highly selective of our clients. We are seeking those who have innovative products with great potential for patients, and who want to see their products positioned to have the best opportunity to get to market.
Our clients are those willing to provide the same integrity, professionalism and transparency that we demand of ourselves.
